Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids
Clinical trial NCT01441635 · COMPLETED
Trial details
- NCT number
- NCT01441635
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-08
- Primary completion
- 2013-11-01
- Enrollment
- 271
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.